Regenxbio (RGNX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist

11.985
-0.055-0.46%

Trading Aug 8 13:42 ET

592.34MMarket Cap-2287P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
PR NewswireAug 8 07:05 ET
Wall Street Analysts Think Regenxbio (RGNX) Could Surge 234.37%: Read This Before Placing a Bet
Yahoo FinanceAug 6 09:55 ET
RegenXBio Grants RSUs to Executives Amidst Leadership Transition
TipRanksAug 6 06:33 ET
Barclays Maintains Overweight on Regenxbio, Lowers Price Target to $50
BenzingaAug 5 19:52 ET · Ratings
Regenxbio Analyst Ratings
BenzingaAug 5 07:02 ET · Ratings
H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Raises Target Price to $39
Moomoo NewsAug 5 06:31 ET · Ratings

Comments

Bingrru

Aug 1 09:20

$Regenxbio (RGNX.US)$

2F KILL CHEATERS

Mar 5 11:19

$Regenxbio (RGNX.US)$ SELL SELL SELL NOW EASY MONEY AND ENJOIN YOURS TAKE BREAK TOMORROW 💰💰💰😋😋😋🤩🤩🤩

Moomoo AI

Feb 17 07:06

Investors' pessimism about the company's revenue prospects may be causing the low P/S ratio. The company's forecast growth is lower than the wider industry, which could be contributing to the depressed P/S. It's hard to see the share price rising strongly in the near future given these circumstances.